Dr. Luke. V. Schneider holds a PhD in Chemical Engineering from Princeton University, an MSES and BSES in Chemical Engineering and a BA in Biology from the University of South Florida. His academic research has been in systems biology. He was the founder and Chief Scientific Officer for Target Discovery, Inc (1999-2017) and its high-performance scientific computing subsidiary Veritomyx, Inc. He was a founding Board member of Aromyx, Inc. (2005-2016). He holds 25 issued patents in seven different fields. Dr. Schneider has served as adjunct faculty at Drexel University (Philadelphia, PA), San Jose State University (San Jose, CA, USA), and as a Senior Lecturer at the University of Canterbury (Christchurch, NZ). While at SRI International, Dr. Schneider led an international team of 82 researchers developing up-converting phosphors as a reporter system for immuno- and nucleic acid-based diagnostics, this was licensed commercially to Orasure Technologies. He led the team that won the first Monsanto Million Dollar Challenge and worked on the team that won the second Challenge. Prior to returning to graduate school at Princeton, Dr. Schneider worked as a Research Engineer at Dupont (Experimental Station) as part of the team developing Group Transfer Polymerization and then as part of a new venture developing a biological treatment alternative for cyanide wastes, ultimately licensed. Dr. Schneider’s primary research interests have been in mathematical modeling of biological and biochemical systems and bioseparations and biomolecule characterization. Natural Extraction Technologies, Ltd., is currently commercializing technology he developed at the University of Canterbury to produce high-value, high-purity, dietary supplement oils from agricultural wastes.